# Lyndsay N. Harris

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lyndsay-n-harris/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,800 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 68 |
| i10-index | 155 |
| Last Known Institution | National Institutes of Health |
| OpenAlex ID | https://openalex.org/A5021514634 |
| ORCID iD | https://orcid.org/0000-0002-9774-6719 |
| Works | 482 |

## Researcher papers

- [American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer](https://scholariq.org/papers/american-society-of-clinical-oncology-2007-update-of-recommendations-for-the-use/)
- [Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib](https://scholariq.org/papers/molecular-heterogeneity-and-response-to-neoadjuvant-human-epidermal-growth/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Researcher university

- [National Institutes of Health](https://scholariq.org/institutions/national-institutes-of-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
